Low, J E <br/><br/>
Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanisms.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Jun 1995 
 - 930-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/00005344-199506000-00011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenergic alpha-Antagonists--administration & dosage<br/>Adrenergic beta-Antagonists--administration & dosage<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Blood Pressure--drug effects<br/>Cardiomegaly--chemically induced<br/>Catecholamines--blood<br/>Cells, Cultured<br/>Creatine Kinase--metabolism<br/>Disease Models, Animal<br/>Glycogen--metabolism<br/>Heart--drug effects<br/>Heart Rate--drug effects<br/>Infusion Pumps, Implantable<br/>Infusions, Intravenous<br/>L-Lactate Dehydrogenase--metabolism<br/>Microscopy, Electron<br/>Myocardium--cytology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Tetrazoles--administration & dosage<br/>Thiophenes--administration & dosage